An executive leader at Induction Healthcare Group is to stand down from the role.

Dr Hugo Stephenson, who has performed the group executive director role since the start of COVID-19, will return to the non-executive director position he assumed on admission to the AIM segment of the London Stock Exchange in May 2019.

The virtual care platform, one of our HealthTech 50 companies, recently reported strong growth for the 2022 financial year.

Dr Stephenson is based in Australia. Induction said the decision was taken due to “the opportunities for face-to-face interaction which are now possible for the UK-based executive and senior management team as borders reopen”.

It follows the completion of the integration of the Attend Anywhere acquisition – where most of the team was based in Australia – and the most recently announced successful renewals of Induction Attend Anywhere across NHS England.

The company is led by a UK-based team of CEO James Balmain and CFO Guy Mitchell. Dave Williams joined as chief technology officer in September 2021.

“James and his team have delivered a really strong end to FY22, providing an exemplary outcome for Attend Anywhere contract renewals, generating substantial demand for Zesty as the NHS emerges from pandemic pressures, and establishing a coordinated, global product and technology organisation that is already demonstrating increased delivery capability and cross-product efficiency under Dave Williams’ leadership,” said Dr Stephenson.

“From the outset I have imagined Induction Healthcare as an enabler for flexible care around the world allowing healthcare systems to offer patients and providers a range of digital and in-person care options beyond the resource constrained ‘bricks and mortar’ models historically available through hospitals. 

“I stepped into an executive role at the beginning of the pandemic – from a locked-down basement in Australia – to provide Induction with stability at a time of great global uncertainty and then a physical link with the Attend Anywhere team post acquisition. 

“My heart remains in inspiring Induction to scale worldwide following the impact we are already making in the UK. I am looking forward to focusing on this mission which I can now do much more efficiently and effectively from a non-executive position on our board.”

Balmain added: “We are indebted to Hugo for his immense contribution to the business since the commencement of the pandemic during a period of uncertainty, changing rules, opportunities and challenges. 

“As we evolve and expand internationally, I’m delighted that Induction will continue to benefit from his experience and expertise. We all are incredibly excited about the future prospects for the business.”